Literature DB >> 2455054

Production and characterisation of mouse monoclonal antibodies reacting with the lipopolysaccharide core region of gram-negative bacilli.

B J Appelmelk1, A M Verweij-van Vught, J J Maaskant, W F Schouten, A J De Jonge, L G Thijs, D M Maclaren.   

Abstract

Monoclonal antibodies to the lipopolysaccharide (LPS) core region were produced by immunising mice with Escherichia coli strain J5 (chemotype Rc). One of these bound to the deepest part of the core, i.e., Lipid A, and reacted with other heat-killed but not live gram-negative bacilli, including E. coli, Klebsiella pneumoniae and Pseudomonas aeruginosa. Eight other monoclonal antibodies, binding to the terminal glucose residue of Rc LPS, reacted with live cells of E. coli strains only. Thus, the O antigen does not necessarily render the core inaccessible to antibody. However, despite binding to live bacteria, these monoclonal antibodies neither enhanced phagocytic killing, nor protected mice from dying from gram-negative infection or endotoxaemia. It is concluded that antibodies reacting with the most immunodominant parts of the J5 core are not protective.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2455054     DOI: 10.1099/00222615-26-2-107

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  10 in total

1.  Characterization of the epitope specificity of murine monoclonal antibodies directed against lipid A.

Authors:  H M Kuhn; L Brade; B J Appelmelk; S Kusumoto; E T Rietschel; H Brade
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

Review 2.  Immunoprophylaxis and immunotherapy of gram-negative sepsis and shock with antibodies to core glycolipids and lipid A of bacterial lipopolysaccharides.

Authors:  I G Mitov; D G Terziiski
Journal:  Infection       Date:  1991 Nov-Dec       Impact factor: 3.553

3.  Murine monoclonal antibodies to Klebsiella pneumoniae protect against lethal endotoxemia and experimental infection with capsulated K. pneumoniae.

Authors:  E Mandine; M F Salles; R Zalisz; M Guenounou; P Smets
Journal:  Infect Immun       Date:  1990-09       Impact factor: 3.441

4.  Anti-lipid A monoclonal antibody centoxin (HA-1A) binds to a wide variety of hydrophobic ligands.

Authors:  E J Helmerhorst; J J Maaskant; B J Appelmelk
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

5.  Similarities and disparities between core-specific and O-side-chain-specific antilipopolysaccharide monoclonal antibodies in models of endotoxemia and bacteremia in mice.

Authors:  S Bailat; D Heumann; D Le Roy; J D Baumgartner; E T Rietschel; M P Glauser; F Di Padova
Journal:  Infect Immun       Date:  1997-02       Impact factor: 3.441

6.  Structural Basis for Antibody Recognition of Lipid A: INSIGHTS TO POLYSPECIFICITY TOWARD SINGLE-STRANDED DNA.

Authors:  Omid Haji-Ghassemi; Sven Müller-Loennies; Teresa Rodriguez; Lore Brade; Paul Kosma; Helmut Brade; Stephen V Evans
Journal:  J Biol Chem       Date:  2015-06-17       Impact factor: 5.157

7.  An artificial glycoconjugate containing the bisphosphorylated glucosamine disaccharide backbone of lipid A binds lipid A monoclonal antibodies.

Authors:  L Brade; O Holst; H Brade
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

8.  A broadly cross-protective monoclonal antibody binding to Escherichia coli and Salmonella lipopolysaccharides.

Authors:  F E Di Padova; H Brade; G R Barclay; I R Poxton; E Liehl; E Schuetze; H P Kocher; G Ramsay; M H Schreier; D B McClelland
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

9.  The Combining Sites of Anti-lipid A Antibodies Reveal a Widely Utilized Motif Specific for Negatively Charged Groups.

Authors:  Omid Haji-Ghassemi; Sven Müller-Loennies; Teresa Rodriguez; Lore Brade; Hans-Dieter Grimmecke; Helmut Brade; Stephen V Evans
Journal:  J Biol Chem       Date:  2016-03-01       Impact factor: 5.157

10.  Anti-endotoxin monoclonal antibodies inhibit secretion of tumor necrosis factor-alpha by two distinct mechanisms.

Authors:  R S Burd; R J Battafarano; C S Cody; M S Farber; C A Ratz; D L Dunn
Journal:  Ann Surg       Date:  1993-09       Impact factor: 12.969

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.